Seagen Inc.

BOTHELL, WA How do I update this listing?

Create Email Alert

Seagen is based out of Bothell. Discovers and develops monoclonal antibody-based therapeutic products for the treatment of cancer and immunologic diseases. As of Dec. 31, 2004, the company had three product candidates in clinical trials: SGN-30 (lymphoma); SGN-15 (non-small cell lung cancer); and SGN-40 (multiple myeloma).Whalewisdom has at least 3 13D filings, 1 13G filings, and 310 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2009-06-01. The notice included securities offered of Equity

Contact Info

seagen inc.
21823 30TH DRIVE SE
BOTHELL WA    98021

Business Phone: 4255274000
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Current 13D/G Holdings
Stock Sector Shares Held Market Value Rank Source Source Date
Pieris Pharmaceuticals Inc (PIRS) HEALTH CARE 3,706,184 19,160,971.28 1 13G 2021-03-24

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2009-06-01 D OTHER Equity 11,451,745 11,451,745 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
CLAY B. SIEGALL subscription required
    EXECUTIVE OFFICER DIRECTOR
DANIEL F. HOTH subscription required
    DIRECTOR
DANIEL G. WELCH subscription required
    DIRECTOR
DAVID W. GRYSKA subscription required
    DIRECTOR
ERIC L. DOBMEIER subscription required
    EXECUTIVE OFFICER
FELIX BAKER subscription required
    DIRECTOR
FRANKLIN M. BERGER subscription required
    DIRECTOR
JOHN P. MCLAUGHLIN subscription required
    DIRECTOR
MARK E. LIPPMAN subscription required
    DIRECTOR
MORRIS Z. ROSENBERG subscription required
    EXECUTIVE OFFICER
SRINIVAS AKKARAJU subscription required
    DIRECTOR
THOMAS C. REYNOLDS subscription required
    EXECUTIVE OFFICER
TODD E. SIMPSON subscription required
    EXECUTIVE OFFICER

Elevate your investments